Table 3 |
||||
|
Blood pressure measurements in subjects with stage 1 hypertension and in subjects with prehypertension after daily intake of a placebo, or MPH 1 or MPH 2 for 4 weeks1 |
||||
|
Stage 1 hypertension |
Prehypertension |
|||
|
|
||||
|
Systolic BP |
Diastolic BP |
Systolic BP |
Diastolic BP |
|
|
|
||||
|
Placebo |
150.4 ± 8.9 |
92.0 ± 8.5 |
128.4 ± 5.1 |
80.4 ± 4.8 |
|
MPH 1 |
146.6 ± 10.8* |
89.7 ± 8.7* |
130.0 ± 8.1 |
81.1 ± 6.2 |
|
MPH 2 |
149.9 ± 10.0 |
92.0 ± 7.8 |
128.9 ± 8.4 |
81.2 ± 6.2 |
|
|
||||
|
1 Data are presented as mean ± SD; * denotes significant difference vs. placebo |
||||
|
Boelsma and Kloek Nutrition Journal 2010 9:52 doi:10.1186/1475-2891-9-52 |
||||
